Iovance Biotherapeutics, Inc. Common Stock vs. Twist Bioscience Corporation Common Stock
IOVA
Iovance Biotherapeutics, Inc. Common Stock
$10.65 +4.56%
VS TWSTTwist Bioscience Corporation Common Stock
$159.21 -3.28%
Twist Bioscience Corporation Common Stock (TWST) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| IOVA | TWST | |
|---|---|---|
| Market Cap | $4.62 billion | $10.91 billion |
| Revenue (TTM) | — | $431.80 million |
| Net Income (TTM) | — | $-136,717,000 |
TWST leads on 1 of 1 size & scale factors.
Valuation
| IOVA | TWST | |
|---|---|---|
| Price / Book | — | 24.48 |
| Price / Sales | — | 25.27 |
IOVA and TWST split the valuation factors evenly.
Profitability
| IOVA | TWST | |
|---|---|---|
| Net Margin | — | -31.66% |
| Return on Equity | — | -30.67% |
IOVA and TWST split the profitability factors evenly.
Risk & Sentiment
| IOVA | TWST | |
|---|---|---|
| Short Interest | 0.81% | 0.08% |
TWST leads on 1 of 1 risk & sentiment factors.
Dig deeper: IOVA overview, IOVA financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.